Glen D.  Stettin net worth and biography

Glen Stettin Biography and Net Worth

Glen heads up clinical products, our Therapeutic Resource Centers,℠ channel, trend and formulary management, as well as integrated health solutions. Glen joined Express Scripts when the company merged with Medco in April 2012. During his 17 years at Medco, he served in leadership roles in the clinical, operations, technology and product organizations.

Glen earned his bachelor and medical degrees through Lehigh University and the Medical College of Pennsylvania. He completed his residency in internal medicine at the University of California, San Francisco, where he also served as Medical Chief Resident at Moffitt-Long Hospital, Fellow in cardiology and Robert Wood Johnson Foundation Clinical Scholar at UCSF and Stanford University.

What is Glen D. Stettin's net worth?

The estimated net worth of Glen D. Stettin is at least $3.11 million as of January 11th, 2018. Dr. Stettin owns 33,715 shares of Express Scripts stock worth more than $3,112,906 as of April 27th. This net worth estimate does not reflect any other assets that Dr. Stettin may own. Learn More about Glen D. Stettin's net worth.

How do I contact Glen D. Stettin?

The corporate mailing address for Dr. Stettin and other Express Scripts executives is ONE EXPRESS WAY, SAINT LOUIS MO, 63121. Express Scripts can also be reached via phone at 314-996-0900 and via email at [email protected]. Learn More on Glen D. Stettin's contact information.

Has Glen D. Stettin been buying or selling shares of Express Scripts?

Glen D. Stettin has not been actively trading shares of Express Scripts during the last quarter. Most recently, Glen D. Stettin sold 3,449 shares of the business's stock in a transaction on Thursday, January 11th. The shares were sold at an average price of $81.00, for a transaction totalling $279,369.00. Following the completion of the sale, the vice president now directly owns 33,715 shares of the company's stock, valued at $2,730,915. Learn More on Glen D. Stettin's trading history.

Who are Express Scripts' active insiders?

Express Scripts' insider roster includes Phyllis Anderson (VP), James Havel (Exec. VP & CFO ), Christine Houston (Insider), Christopher McGinnis (VP), Everett Neville (VP), Glen Stettin (VP), and Timothy Wentworth (CEO). Learn More on Express Scripts' active insiders.

Glen D. Stettin Insider Trading History at Express Scripts

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/11/2018Sell3,449$81.00$279,369.0033,715View SEC Filing Icon  
1/2/2018Sell3,448$76.00$262,048.00View SEC Filing Icon  
3/2/2015Sell2,674$84.39$225,658.86View SEC Filing Icon  
2/25/2015Sell27,603$87.55$2,416,642.65View SEC Filing Icon  
11/28/2014Sell10,800$82.96$895,968.00View SEC Filing Icon  
See Full Table

Glen D. Stettin Buying and Selling Activity at Express Scripts

This chart shows Glen D Stettin's buying and selling at Express Scripts by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Express Scripts Company Overview

Express Scripts logo
Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company's PBM segment offers clinical solutions; and specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, public exchange, administration of group purchasing organization, and digital consumer health and drug information services. This segment also provides Medicare, Medicaid, and health insurance marketplace products; Express Scripts SafeGuardRx, a suite of solutions targeting the therapy classes that pose clinical challenges and budgetary threat to its clients; and Inside Rx, a program that provide affordable access to medication for uninsured and underinsured individuals. Its Other Business Operations segment distributes specialty pharmaceuticals and medical supplies, including injectable and infusible pharmaceuticals and medications to treat specialty and rare/orphan diseases. This segment also provides medical benefit management solutions for radiology, cardiology, musculoskeletal disorders, sleep disorders, post-acute care, genetic lab, specialty pharmacy, and medical oncology. The company serves managed care organizations, health insurers, third-party administrators, employers, union-sponsored benefit plans, workers' compensation plans, government health programs, providers, clinics, hospitals, and others. As of December 31, 2017, it operated 4 automated dispensing home delivery pharmacies; 1 non-automated dispensing home delivery pharmacy; 7 non-dispensing order processing centers; 5 patient contact centers; 9 specialty home delivery pharmacies; and 34 specialty branch pharmacies. The company was formerly known as Aristotle Holding, Inc. and changed its name to Express Scripts Holding Company in April 2012. Express Scripts Holding Company was founded in 1986 and is headquartered in Saint Louis, Missouri.
Read More

Today's Range

Now: $92.33
Low: $92.11
High: $95.87

50 Day Range

MA: $92.33
Low: $92.33
High: $92.33

2 Week Range

Now: $92.33
Low: $66.93
High: $101.73

Volume

31,612,912 shs

Average Volume

6,636,970 shs

Market Capitalization

$52.06 billion

P/E Ratio

13.00

Dividend Yield

N/A

Beta

0.88